awmsg logo



paliperidone (Invega®)


Reference No. 455

Publication date:
18/03/2011


Appraisal information

paliperidone (Invega®) prolonged-release tablet


Company: Janssen-Cilag Ltd
BNF category: Central nervous system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: Not available

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, paliperidone (Invega®) cannot be endorsed for use within NHS Wales for the treatment of psychotic or manic symptoms of schizoaffective disorder.
Statement of Advice (SOA)
Download